Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000490195 | SCV000577500 | pathogenic | not provided | 2017-03-28 | criteria provided, single submitter | clinical testing | The c.4006 -1 G>A splice site pathogenic variant in the TSC2 gene destroys the canonical splice acceptor site in intron 33. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. Additionally, this variant has been reported in association with seizures in a child and parent (TSC2 LOVD). Furthermore, the c.4006 -1 G>A variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). |
MGZ Medical Genetics Center | RCV002289659 | SCV002581220 | pathogenic | Tuberous sclerosis 2 | 2021-10-18 | criteria provided, single submitter | clinical testing |